• Explore /
  • Poster
  • / Analysis of primary and acquired resistance to cetuximab from multiomic data in the New EPOC trial.

Analysis of primary and acquired resistance to cetuximab from multiomic data in the New EPOC trial.

Abstract Poster

Authors

null

Sian Alexandra Pugh

Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Sian Alexandra Pugh , Enric Domingo , Susan D Richman , Philip D Dunne , Keara Redmond , Andrew Blake , Zina Eminton , Ian Tomlinson , Timothy S. Maughan , John Neil Primrose , John A Bridgewater

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

22944367

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 3577)

DOI

10.1200/JCO.2023.41.16_suppl.3577

Abstract #

3577

Poster Bd #

277

Abstract Disclosures

Similar Posters

First Author: Daniela Adua

First Author: Ramya Thota

First Author: Samuel A. Jacobs

First Author: Liu Li